Stuart Chaussee & Associates’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-165
Closed -$8K 250
2021
Q1
$8K Buy
+165
New +$8K ﹤0.01% 143